OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 9.34 EUR -3.81% Market Closed
Market Cap: 203.2m EUR
Have any thoughts about
OSE Immunotherapeutics SA?
Write Note

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 14.5 EUR with a low forecast of 10.91 EUR and a high forecast of 22.37 EUR.

Lowest
Price Target
10.91 EUR
17% Upside
Average
Price Target
14.5 EUR
55% Upside
Highest
Price Target
22.37 EUR
139% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
ADAG
Adagene Inc
339% Upside
SGMO
Sangamo Therapeutics Inc
43% Upside
1672
Ascletis Pharma Inc
25% Upside
ARWR
Arrowhead Pharmaceuticals Inc
124% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
41% Upside
RXRX
Recursion Pharmaceuticals Inc
36% Upside
ABOS
Acumen Pharmaceuticals Inc
327% Upside
MRUS
Merus NV
76% Upside

Revenue
Forecast

Revenue Estimate
OSE Immunotherapeutics SA

For the last 8 years the compound annual growth rate for OSE Immunotherapeutics SA's revenue is 120%. The projected CAGR for the next 3 years is 233%.

120%
Past Growth
233%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
14.5 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 14.5 EUR with a low forecast of 10.91 EUR and a high forecast of 22.37 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
233%

For the last 8 years the compound annual growth rate for OSE Immunotherapeutics SA's revenue is 120%. The projected CAGR for the next 3 years is 233%.

Back to Top